Paper17560695
Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
De Wals P and 5 others. Vaccine, 2007. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. Papers, record 17560695. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560695
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunization, Secondary | Major topic |
| Meningococcal Infections | Major topic |
| Meningococcal Vaccines | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Canada | |
| Child | |
| Child, Preschool | |
| Cost-Benefit Analysis | |
| Humans | |
| Infant | |
| Middle Aged |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41345602 | Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States. | BMC Public Health | 2025 | https://conductscience.org/library/papers/41345602 | PubMed |
| 39250492 | Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China. | PLoS One | 2024 | https://conductscience.org/library/papers/39250492 | PubMed |
| 38348600 | Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/38348600 | PubMed |
| 33631080 | Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/33631080 | PubMed |
| 31907760 | Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada. | Can J Public Health | 2020 | https://conductscience.org/library/papers/31907760 | PubMed |
| 31885753 | Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story. | Can J Infect Dis Med Microbiol | 2019 | https://conductscience.org/library/papers/31885753 | PubMed |
| 31754924 | Economic evaluation of meningococcal vaccines: considerations for the future. | Eur J Health Econ | 2020 | https://conductscience.org/library/papers/31754924 | PubMed |
| 31680692 | Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories. | Can Commun Dis Rep | 2010 | https://conductscience.org/library/papers/31680692 | PubMed |
| 28484344 | Economic evaluations of vaccines in Canada: a scoping review. | Cost Eff Resour Alloc | 2017 | https://conductscience.org/library/papers/28484344 | PubMed |
| 28472165 | Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada. | PLoS One | 2017 | https://conductscience.org/library/papers/28472165 | PubMed |
| 26890128 | Economic evaluation of vaccines in Canada: A systematic review. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/26890128 | PubMed |
| 26651380 | Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26651380 | PubMed |
| 23741448 | Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands. | PLoS One | 2013 | https://conductscience.org/library/papers/23741448 | PubMed |
| 20465314 | Methodological concerns with economic evaluations of meningococcal vaccines. | Pharmacoeconomics | 2010 | https://conductscience.org/library/papers/20465314 | PubMed |
| 20364530 | Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go? | Can J Public Health | 2010 | https://conductscience.org/library/papers/20364530 | PubMed |
| 19908924 | Cost effectiveness of herpes zoster vaccine in Canada. | Pharmacoeconomics | 2009 | https://conductscience.org/library/papers/19908924 | PubMed |
| 17709404 | Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. | CMAJ | 2007 | https://conductscience.org/library/papers/17709404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17560695
GET https://conductscience.org/api/papers/v1/17560695/authors